Mental Retardation Clinical Trial
Verified date | October 2018 |
Source | Neurogen Brain and Spine Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was to analyze the benefit of autologous mononuclear cell therapy in mental retardation.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | September 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 6 Months to 40 Years |
Eligibility |
Inclusion Criteria: - diagnosed cases of mental retardation - age above 6 months Exclusion Criteria: - presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus - malignancies - bleeding tendencies - pneumonia - renal failure - severe liver dysfunction - severe anemia [Hemoglobin < 8] - any bone marrow disorder - space occupying lesion in brain - other acute medical conditions such as respiratory infection and pyrexia |
Country | Name | City | State |
---|---|---|---|
India | Neurogen brain and spine institute | Navi Mumbai | Maharashtra |
Lead Sponsor | Collaborator |
---|---|
Neurogen Brain and Spine Institute |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in common clinical symptoms of mental retardation | Change in symptoms such as cognition, remote memory, problem solving,understanding of relationships,social interaction,communication,self care, activities of daily living will be recorded at 1 year follow up. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02791321 -
Fragility Assessment in Adults With ADHD and Mental Retardation
|
N/A | |
Recruiting |
NCT01908400 -
Safety and Efficacy of BMMNCin Patients With Mental Retardation
|
Phase 1/Phase 2 | |
Completed |
NCT00156221 -
MR Scanning of Very Young Children With Severe Developmental Disorders
|
N/A | |
Recruiting |
NCT00491478 -
Repetitive Behavior Disorders in People With Severe Mental Retardation
|
Phase 3 | |
Terminated |
NCT02797418 -
"Cognitus & Moi": a New Cognitive Remediation Tool
|
N/A | |
Completed |
NCT00758108 -
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
|
||
Completed |
NCT01430845 -
Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
|
||
Not yet recruiting |
NCT02214745 -
Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community
|
N/A | |
Active, not recruiting |
NCT00552526 -
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
|
Phase 4 | |
Completed |
NCT02943304 -
Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
|
||
Completed |
NCT00491894 -
Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions
|
Phase 3 | |
Completed |
NCT01291238 -
School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability.
|
N/A | |
Completed |
NCT01456910 -
Resistance Training Program, Labor Inclusion, Intellectual Disability
|
N/A | |
Completed |
NCT00065273 -
Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay
|
Phase 3 | |
Active, not recruiting |
NCT00065936 -
Self-Injury: Diagnosis and Treatment
|
Phase 3 | |
Completed |
NCT00506259 -
Treatment Strategies for Children With Smith-Magenis Syndrome
|
Phase 1 | |
Not yet recruiting |
NCT05442229 -
A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
|
||
Active, not recruiting |
NCT06370793 -
Ningbo Severe Mental Disorders Cohort
|
||
Completed |
NCT01517048 -
Brain-Derived Neurotrophic Factor in Obesity and Brain Function
|
||
Completed |
NCT03847753 -
Exploring the Comorbidity Between Mental Disorders and General Medical Conditions
|